Mayo Clinic Pancreatic and Hepato-Biliary Cancer Symposium 2018
From October 26, 2018 23:00 until October 27, 2018 01:00
Save to calendar
Course Directors: Ramesh Ramanathan, M.D., Mitesh Borad, M.D., Daniel Von Hoff, M.D. and Tanios S. Bekaii-Saab, M.D.
Nationally and internationally renowned faculty provide a state-of-the-art update on the latest treatment options for patients with hepato-biliary and pancreatic cancers. The program is designed to provide a multi-disciplinary overview on the importance of early diagnosis and treatment considerations, including surgery and new pharmacological agents, and how to incorporate these into clinical practice. There will also be a focus on emerging immuno-oncology and molecular profile options.
Topics include: cancer imaging and staging for the non-radiologist; molecular biology and translational research advances of pancreatic and hepato-biliary cancers, local therapy, surgery and liver transplantation for hepato-biliary cancers; adjuvant therapy and preoperative therapy of pancreatic and hepato-biliary cancers; molecularly targeted agents and treatment of molecular subsets for pancreatic and hepatobiliary cancers; rational sequencing of therapies for advanced pancreatic and hepatobiliary cancers.
This course is intended for surgeons, gastroenterologists, medical and radiation oncologists, laboratory scientists, physician assistants, nurse practitioners, registered nurses, oncology pharmacists, oncology nurses and clinical research personnel. Specialties include: medical oncology, hematology, gastroenterology, radiation oncology, surgical oncology, pathology, radiology and laboratory research science.
Upon conclusion of this program, participants should be able to:
- Identify patients who will benefit from preoperative therapy prior to surgery
- Describe the differences in staging between borderline and unresectable locally advanced pancreatic and hepato-biliary cancers
- Identify patients with resecetable pancreatic cancer who are candidates for a minimally invasive procedure
- Identify patients suitable for a liver transplant
- Integrate novel agents in clinical care and clinical trial participation
- Describe molecular biology of pancreatic and hepato-bilary cancers
- Recognize the appropriate regimen for first and second line therapy in treating advanced pancreatic cancer and hepato-biliary cancer
- Demonstrate state of the art therapy for neuroendocrine of the pancreas
Attendance at this Mayo Clinic course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course.
Endorsed by the IASGO
Visit the Symposium website!